Luayon, Vilma .
HRN: 21-73-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFUROXIME 500MG (TAB)
08/12/2022
08/16/2022
PO
500mg Tab
BID
S/P Exploratory Laparotomy; Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes